<i>In vitro</i> drug susceptibility of a panel of recent clinical <i>L</i>. <i>infantum</i> isolates against antileishmanial reference drugs in THP-1, bone-marrow derived macrophag... by Sarah Hendrickx (321143)

Exploring reopening strategies for high disease transmission <i>v</i>_<i>r</i> with testing capacity. by Mackenzie Dalton (14093874)

Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

“…Control (wild type), <i>rbm-26 (cue23[P80L])</i> and <i>rbm-26 (cue34[L13V])</i> data in panels A, B, and C have been reused from Figs <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002876#pbio.3002876.g002" target="_blank">2D, 2F</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002876#pbio.3002876.g005" target="_blank">5C</a>, respectively. …”

Exploring reopening strategies for low disease transmission <i>v</i>_<i>r</i> with testing capacity. by Mackenzie Dalton (14093874)

Proportion of time spent in the Start Room or Avoidance Room or showing a behaviour (Stimulus Contact) presented across stimuli and separately for female (n = 10) and male (n = 10)... by Sara Hintze (3216885)

DataSheet_1_Integrin Alpha V in Urine: A Novel Noninvasive Marker for Prostate Cancer Detection.docx by Marina Y. Zemskova (10279895)

“…<p>Prostate cancer (PCa) diagnosis based on patient urine analysis provides non-invasive and promising method as compared to biopsy and a prostate-specific antigen (PSA) test. This study was conceived to investigate whether Integrin alpha V (ITGAV) protein is present in urine and assess the urinary ITGAV diagnostic potential for PCa. …”

Heatmap comparing the metabolites extracted from feces of NOD mice at different times point pre- and post-vaccination using GC-MS. by Jacob Cobb (6400340)

“…Metabolite average relative percentages of 5 mice at each time point are displayed as blue bars. …”

Generation and life span of <i>Rap1</i> knockin mice. by Amanda J. Stock (3139719)

(A-C) Force versus drill depth and torque versus drill depth. by Marsel Ganeyev (21453399)

Kifunensine reduces the titer of live SARS-CoV-2 BA.1.1, but not D614G or Delta variant. by Sabrina Lusvarghi (2329267)

Ripe Ora-pro-nobis (Pereskia aculeata miller) fruits express high contents of bioactive compounds and antioxidant capacity by Aline Priscilla Gomes da Silva (5221931)

Table_5_Evolution of Advanced Chronic Lymphoid Leukemia Unveiled by Single-Cell Transcriptomics: A Case Report.xlsx by Pavel Ostasov (9584723)

Table_5_Characterization and transcriptomic analysis of a native fungal pathogen against the rice pest Nilaparvata lugens.XLSX by Zheng-Liang Wang (4921291)

“…RNAi-mediated knockdown of an upregulated gene encoding a serine protease (NlSPN) could cause a significant decrease in BPH survival. …”

Expression of cytokines and chemokines in female and male <i>Rap1</i> knockin serum, BMDMs, and tissues. by Amanda J. Stock (3139719)

Effectiveness of the available COVID-19 primary and booster vaccination schemes against laboratory-confirmed infections during the different waves. by Rima Moghnieh (679199)

Subjects:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against acute-care hospitalization attributed to laboratory-confirmed infections during the differen... by Rima Moghnieh (679199)

Subjects:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Alpha variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.1/BA.2 variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. by Rima Moghnieh (679199)

Subjects: